Drugs / KANOKAD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01961804 | Mar 2014 → Feb 2020 | disseminated intravascular coagulation, hemorrhagic disease, traumatic brain injury | University Hospital, Angers | Terminated | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KANOKAD | “Administration of prothrombin complex concentrates: KANOKAD before CT Scan” NCT01961804 ↗ |
| Modality | Protein / enzyme biologic | “four-factor prothrombin complex concentrate (4f-PCC)” PMID 40315031 ↗ Nov 2024 |